MunshiMN, SlyneC, GreenbergJM, et al.Nonadherence to insulin therapy detected by Bluetooth-enabled pen cap is associated with poor glycemic control. Diabetes Care, 2019; 42: 1129–1131.
2.
PatelPJ, BenasiK, FerrariG, et al.Randomized trial of infusion set function: steel versus teflon. Diabetes Technol Ther, 2014; 16: 15–19.
3.
HauzenbergerJR, Hipszer BR, LoeumC, et al.Detailed analysis of insulin absorption variability and the tissue response to continuous subcutaneous insulin infusion catheter implantation in swine. Diabetes Technol Ther, 2017; 19: 641–650.
4.
NorgaardK, ShinJ, WelshJB, et al.Performance and acceptability of a combined device for insulin infusion and glucose sensing in the home setting. J Diabetes Sci Technol, 2015; 9: 215–220.
5.
RumplerM, MaderJC, FischerJP, et al.First application of a transcutaneous optical single-port glucose monitoring device in patients with type 1 diabetes mellitus. Biosens Bioelectron, 2017; 88: 240–248.
6.
TschaiknerM, SimicA, JungklausM, et al.Development of a single-site device for conjoined glucose sensing and insulin delivery in type-1 diabetes patients. IEEE Trans Biomed Eng, 2020; 67: 312–322.
7.
GirardotS, MousinF, VezubetJ, et al.Kalman filter-based novel methodology to assess insulin pump accuracy. Diabetes Technol Ther, 2019; 21: 557–565.
8.
LeelarathnaL, RobertsSA, HindleA, et al.Comparison of different insulin pump makes under routine care conditions in adults with Type 1 diabetes. Diabet Med, 2017; 34: 1372–1379.
CarrollMF, SchadeDS. The dawn phenomenon revisited: implications for diabetes therapy. Endocr Pract, 2005; 11: 55–64.
11.
ShahVN, GrimsmannJM, FosterNC, et al.Undertreatment of cardiovascular risk factors in the type 1 diabetes exchange clinic network (United States) and the prospective diabetes follow-up (Germany/Austria) registries. Diabetes Obes Metab, 2020; 22: 1577–1585.
12.
GhanimH, BatraM, GreenK, et al. Liraglutide treatment in overweight and obese patients with type 1 diabetes: a 26-week randomized controlled trial; mechanisms of weight loss. Diabetes Obes Metab 2020 May 19. DOI: 10.1111/dom.14090 [Epub ahead of print].
13.
BellKJ, SmartCE, SteilGM, et al.Impact of fat, protein, and glycemic index on postprandial glucose control in type 1 diabetes: implications for intensive diabetes management in the continuous glucose monitoring era. Diabetes Care, 2015; 38: 1008–1015.
14.
PatersonM, BellKJ, O'ConnellSM, et al.The role of dietary protein and fat in glycaemic control in type 1 diabetes: implications for intensive diabetes management. Curr Diab Rep, 2015; 15: 61.
15.
ElleriD, AllenJM, HarrisJ, et al.Absorption patterns of meals containing complex carbohydrates in type 1 diabetes. Diabetologia, 2013; 56: 1108–1117.
16.
PankowskaE, BlazikM, GroeleL. Does the fat-protein meal increase postprandial glucose level in type 1 diabetes patients on insulin pump: the conclusion of a randomized study. Diabetes Technol Ther, 2012; 14: 16–22.
17.
PickupJC, ReznikY, SuttonAJ. Glycemic control during continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 2 diabetes: individual patient data meta-analysis and meta-regression of randomized controlled Trials. Diabetes Care, 2017; 40: 715–722.
